Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys

This publication has 40 references indexed in Scilit:

• Increased dopamine clearance in the non-lesioned striatum of rhesus monkeys with unilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) striatal lesions
  Neuroscience Letters, 1995
• Elevation of neuronal MAO-B activity in a transgenic mouse model does not increase sensitivity to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
  Brain Research, 1994
• MPTP‐induced oxidative stress and neurotoxicity are age‐dependent: Evidence from measures of reactive oxygen species and striatal dopamine levels
  Synapse, 1994
• General overview: Past contributions and future opportunities using aged nonhuman primates
  Neurobiology of Aging, 1993
• Oxidative Stress, Glutamate, and Neurodegenerative Disorders
  Science, 1993
• Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis
  Brain Research, 1990
• Monoamine oxidase, brain ageing and degenerative diseases
  Biochemical Pharmacology, 1989
• Behavioral and biochemical studies in monkeys made hemiparkinsonian by MPTP
  Brain Research, 1987
• Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
  Life Sciences, 1986
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
  Proceedings of the National Academy of Sciences, 1983